News

While patient centricity has been a newfound goal of the pharma industry, many would argue that adopting this philosophy has been more talk than action thus far. eClinicalHealth conducted a case study to learn what patient engagement means to industry professionals.

A patient-centered study design can improve the trial experience by engaging directly with patients. QuintilesIMS recently completed a case study that supported this concept and showed value toward patient recruitment.

A prediction by QuintilesIMS consultants states that the industry can look forward to a historically large number and quality of new medicines emerging from the research and development pipeline over the next five years.

This article provides the necessary steps to advance past Phase II clinical trials on the way toward delivering an impactful drug to market.

The European Reference Network on Rare Respiratory Diseases-a grouping of specialists from more than 60 dispersed centers-has won approval of EU funding to maximize clinical trial efficiency in Europe.

Conducting a clinical trial is a difficult process no matter the factors involved, but become especially challenging when ran from sites that have no prior experience and limited resources. A little preparation and forward thinking can go a long way in reducing data loss and executing a successful study.

Moffitt Cancer Center has chosen cryogenic logistics company, Cryoport to provide support for its immunology program, cancer research, therapy programs and lab moves.

As business grows with the addition of more CROs, questions have arisen from sponsors about how to conduct effective CRO oversight. A survey of clinical leaders provides insights to help address key challenges and regulations more quickly and effectively.

Guido Rasi, Executive Director of the European Medicines Agency, has conceded that the planned exit of the U.K. from the European Union could have a major impact on the activities of the EMA.

Comparing mean vs. median to uncover the full data picture of site-level performance.

The European Medicines Agency will launch a pilot project in February 2017 to test the added value and feasibility of tailored scientific advice for the development of biosimilar medicines.

Schulman IRB has announced that they will join both IRBchoice and SMART IRB Reliance Networks.

Commonwealth Informatics has signed a new contract to support the use of advanced drugs safety tools at the FDA Center for Drug Evaluation and Research and the Center for Biologics Evaluation and Research.

The Almac Group has announced a collaboration with cloud-based solution provider Exostar.

Specimatch announced the launch of its web-based software service for cancer patients and oncologists.

PPD has announced an expansion of its stability sample storage capacity and capabilities.

Spare a thought for your Scandinavian colleagues who are running CROs

The Alliance for Clinical Research Excellence and Safety (ACRES) has partnered with the British Standards Institution (BSI) to launch a multi-stakeholder global working party.